Continued peanut patch use for children who were in earlier studies
Part of Immune system & allergy clinical trials.
This program lets children who have already finished a DBV peanut patch study keep using the Viaskin Peanut patch. It's for kids who want continued access to this peanut allergy treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have already been in a DBV peanut patch study (like the PEOPLE study or a similar one) and completed it (or be in a current one).
- You must be at least 2 years old.
- If you are a female who could become pregnant, you must have a negative pregnancy test and be willing to use birth control.
- You cannot have left a previous DBV peanut patch study early.
- You must not have a widespread skin condition like severe eczema affecting large areas.
- You must not have had an allergic reaction to the patch materials (other than peanut).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests VE416, a treatment meant to help reduce peanut allergy reactions by changing how the immune system responds. If you have documented peanut allergy, you may receive the study medicine and, for some people, take part in a supervised peanut “entry challenge.”
This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
This trial tests a new immunotherapy called UKK-0018 to treat peanut allergies in adults. The goal is to help your body become less sensitive to peanuts over time.
This trial studies whether an immune-supportive diet can improve gut health (gut permeability) in children with confirmed peanut or tree-nut allergy. If you join, the researchers will use allergy testing and gut-related diet approaches to see whether symptoms and gut measures change.
Hear when a new Peanut Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.